Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Raj G. Vaghjiani"'
Autor:
Raj G. Vaghjiani, Joseph J. Skitzki
Publikováno v:
Cancers, Vol 14, Iss 15, p 3748 (2022)
Since its first application in the treatment of cancer during the 1800s, immunotherapy has more recently become the leading edge of novel treatment strategies. Even though the efficacy of these agents can at times be predicted by more traditional met
Externí odkaz:
https://doaj.org/article/c0def3e858d8462497f27ae966475acf
Autor:
Yan Li, David R Jones, Xiaoyu Li, Prasad S Adusumilli, David Restle, Joseph Dux, Alexander J Byun, Jennie K Choe, Raj G Vaghjiani, Carlos Thomas, Kyohei Misawa, Kay See Tan, Navin K Chintala
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 6 (2023)
Background Tumor immune microenvironment (TIME) and cancer antigen expression, key factors for the development of immunotherapies, are usually based on the data from primary tumors due to availability of tissue for analysis; data from metastatic site
Externí odkaz:
https://doaj.org/article/0417d5e6a51344c8a445b3c12686a2ee
Autor:
Prasad S. Adusumilli, Shaohua Lu, Takashi Eguchi, David R. Jones, Kay See Tan, Zachary Tano, Yusuke Takahashi, Raj G. Vaghjiani, William D. Travis, Jordan Dozier, Koji Kameda
Publikováno v:
J Thorac Oncol
In patients with stage IA lung adenocarcinoma (ADC), sublobar resection and tumor spread through air spaces (STAS) are associated with high rates of locoregional recurrence, half of which occur within the regional lymph nodes (LNs). Our objectives we
Autor:
David R. Jones, Prasad S. Adusumilli, Alexandra Poch, Raj G. Vaghjiani, Jordan Dozier, Masha Zeltsman, Alessia Pedoto, Takashi Eguchi
Publikováno v:
Lung Cancer
OBJECTIVE: The goal of this study is to investigate the use of EA and its impact on the postoperative short-term outcomes of patients with non-small cell lung cancer (NSCLC) who received a lobectomy by either minimally invasive surgery (MIS) or thora
Autor:
Xiaoyu Li, Joseph Dux, Yan Li, David R. Jones, Raj G. Vaghjiani, Matthew J. Bott, Jennie Choe, Daniel J. Gross, Waseem Cheema, Rania G. Aly, James M. Isbell, Navin K. Chintala, Kay See Tan, Katsura Emoto, Rachel Grosser, Bob T. Li, William D. Travis, Hua Zheng, Prasad S. Adusumilli
Publikováno v:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 17(1)
Introduction Patients with stage II to III lung adenocarcinomas are treated with adjuvant chemotherapy (ACT) to target the premetastatic niche that persists after curative-intent resection. We hypothesized that the premetastatic niche is a scion of r
Autor:
Shaohua Lu, Prasad S. Adusumilli, David R. Jones, William D. Travis, Raj G. Vaghjiani, Takashi Eguchi, Kay See Tan, Yusuke Takahashi, Koji Kameda
Publikováno v:
Oncotarget
// Yusuke Takahashi 1, 2 , Takashi Eguchi 1, 3 , Koji Kameda 1, 4 , Shaohua Lu 5, 6 , Raj G. Vaghjiani 1 , Kay See Tan 7 , William D. Travis 5 , David R. Jones 1 and Prasad S. Adusumilli 1, 8 1 Thoracic Service, Department of Surgery, Memorial Sloan
Autor:
Raj G. Vaghjiani, Marjorie G. Zauderer, Prasad S. Adusumilli, Takashi Eguchi, Hua Zheng, Masha Zeltsman
Publikováno v:
Immunotherapy. 9(11)
Spurred by the survival benefits seen with the use of checkpoint blockade in non-small-cell lung cancer (NSCLC), there has been a growing interest in the potential applications of immunotherapy. Despite this, the objective response rate for single-ag
Publikováno v:
The Journal of thoracic and cardiovascular surgery. 155(3)
Autor:
Prasad S. Adusumilli, William D. Travis, Takashi Eguchi, Natasha Rekhtman, Katsura Emoto, Yusuke Takahashi, Raj G. Vaghjiani
Publikováno v:
Journal of Thoracic Oncology. 13:S386-S387
Publikováno v:
Seminars in thoracic and cardiovascular surgery. 29(3)